Moore Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.75M | Buy |
+600,000
| New | +$5.75M | 0.07% | 166 |
|
|
2024
Q4 | – | Sell |
-130,000
| Closed | -$2.35M | – | 512 |
|
|
2024
Q3 | $2.35M | Buy |
130,000
+10,000
| +8% | +$181K | 0.04% | 232 |
|
|
2024
Q2 | $1.24M | Hold |
120,000
| – | – | 0.02% | 262 |
|
|
2024
Q1 | $1.27M | Buy |
120,000
+20,000
| +20% | +$212K | 0.02% | 239 |
|
|
2023
Q4 | $913K | Buy |
100,000
+20,000
| +25% | +$183K | 0.02% | 253 |
|
|
2023
Q3 | $830K | Buy |
80,000
+20,000
| +33% | +$207K | 0.02% | 252 |
|
|
2023
Q2 | $859K | Buy |
+60,000
| New | +$859K | 0.01% | 282 |
|